Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Lymphocytic infiltration in gliomas: evidence of possible host resistance.

× No keyword cloud information.

44 in total

1. CD8+ T-cell infiltrate in newly diagnosed glioblastoma is associated with long-term survival.

Authors: Isaac Yang; Tarik Tihan; Seunggu J Han; Margaret R Wrensch; John Wiencke; Michael E Sughrue; Andrew T Parsa
Journal: J Clin Neurosci Date: 2010-08-19 Impact factor: 1.961

2. Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes.

Authors: N G Baldwin; C D Rice; T M Tuttle; H D Bear; J I Hirsch; R E Merchant
Journal: J Neurooncol Date: 1997-03 Impact factor: 4.130

Review 3. Immunotherapy for malignant glioma using human recombinant interleukin-2 and activated autologous lymphocytes. A review of pre-clinical and clinical investigations.

Authors: R E Merchant; M D Ellison; H F Young
Journal: J Neurooncol Date: 1990-04 Impact factor: 4.130

Review 4. Glioblastoma multiforme: morphology and biology.

Authors: K Jellinger
Journal: Acta Neurochir (Wien) Date: 1978 Impact factor: 2.216

5. Characterization of interleukin-2-initiated versus OKT3-initiated human tumor-infiltrating lymphocytes from glioblastoma multiforme: growth characteristics, cytolytic activity, and cell phenotype.

Authors: E A Grimm; J M Bruner; J Carinhas; J A Köppen; W G Loudon; L Owen-Schaub; P A Steck; R P Moser
Journal: Cancer Immunol Immunother Date: 1991 Impact factor: 6.968

6. Treatment of recurrent malignant glioma by repeated intracerebral injections of human recombinant interleukin-2 alone or in combination with systemic interferon-alpha. Results of a phase I clinical trial.

Authors: R E Merchant; D W McVicar; L H Merchant; H F Young
Journal: J Neurooncol Date: 1992-01 Impact factor: 4.130

7. Specific adoptive immunotherapy of malignant glioma with long-term cytotoxic T lymphocyte line expanded in T-cell growth factor. Experimental study and future prospects.

Authors: T Yamasaki; H Handa; J Yamashita; Y Watanabe; Y Namba; M Hanaoka
Journal: Neurosurg Rev Date: 1984 Impact factor: 3.042

Lymphocytic infiltration in gliomas: evidence of possible host resistance.